DOI QR코드

DOI QR Code

Analysis of the Expression Patterns of Thymosin β4, Vascular Endothelial Growth Factor, and Hypoxia-Inducible Factor-1α in Various Tumors Using Tissue Microarray

Tissue microarray를 이용한 여러 암에서의 thymosin β4, vascular endothelial growth factor, 및 hypoxia-inducible factor-1α 발현양상 연구

  • Lee, Bo-Young (Department of Parasitology and Gnenetics, Kosin University College of Medicine) ;
  • Lee, Seung-Hyun (Department of Surgery, Kosin University College of Medicine) ;
  • Ahn, Byung-Kwon (Department of Surgery, Kosin University College of Medicine) ;
  • Ock, Mee-Sun (Department of Parasitology and Gnenetics, Kosin University College of Medicine) ;
  • Cha, Hee-Jae (Department of Parasitology and Gnenetics, Kosin University College of Medicine)
  • 이보영 (고신대학교 의과대학 기생충학 유전학 교실) ;
  • 이승현 (고신대학교 의과대학 외과학 교실) ;
  • 안병권 (고신대학교 의과대학 외과학 교실) ;
  • 옥미선 (고신대학교 의과대학 기생충학 유전학 교실) ;
  • 차희재 (고신대학교 의과대학 기생충학 유전학 교실)
  • Received : 2010.12.23
  • Accepted : 2010.12.30
  • Published : 2011.03.30

Abstract

Thymosin ${\beta}4$ (TB-4) has been reported to play a key role in tumor growth, metastasis and angiogenesis. In addition, TB-4 induced the expression of vascular endothelial growth factor (VEGF) and stabilized the hypoxia-inducible factor (HIF)-$1{\alpha}$ in melanoma cells. Although the importance of thymosin ${\beta}4$ in angiogenesis and metastasis has been proven, there are few studies that show the expression patterns of TB-4, VEGF and HIF-$1{\alpha}$. This study was conducted to analyze the relationship among these proteins in various tumors. Using tissue microarray analysis, we investigated the expression patterns of TB-4, VEGF and HIF-$1{\alpha}$ in various tumors to identify the expression patterns and relationships of these proteins in certain tumors. TB-4 was highly expressed in osteosarcoma, colon adenocarcinoma, esophageal squamous cell carcinoma, kidney and urinary bladder transitional carcinoma, lung cancer, and liver cancer. HIF-$1{\alpha}$ was highly expressed in nasal cavity inverted papilloma, lung cancer, and esophageal squamous cell carcinoma. The expression patterns of TB-4 and HIF-$1{\alpha}$ were almost similar and co-localized. VEGF expression was high in the blood vessels in tumors, but usually not high in the tumors themselves. VEGF was moderately expressed in stomach cancer, liver angiosarcoma, gall bladder adenocarcinoma, and uterus endometrial adenocarcinoma. The expression patterns of VEGF shows similarities in certain tumors including stomach cancer, osteosarcoma, liposarcoma, lung cancer, liver cancer, gall bladder adenocarcinoma, esophageal squamous cell carcinoma, stomach cancer, colorectal carcinoma and renal cell carcinoma. These results suggest that the expression patterns of TB-4, HIF-$1{\alpha}$ and VEGF were co-localized and related to tumorigenesis and angiogenesis of certain tumors.

사이모신 베타 4와 관련 단백질인 HIF-$1{\alpha}$ 및 VEGF의 발현을 여러 인간 암 조직에서 tissue microarray를 사용하여 조사하였다. 사이모신 베타 4는 골육중, 대장 선암, 식도 편평세포암, 신장 및 방광의 이행세포암, 폐암 및 간암에서 많이 발현되었으며 HIF-$1{\alpha}$은 비강 역위성 유두종, 폐암 및 식도 편평세포암에서 강한 발현을 보였으며 대체로 발현되는 양상이나 위치가 사이모신 베타 4와 일치하는 것으로 관찰되었다. VEGF는 암 조직에서보다 암조직에 분포된 혈관내피에서 강하게 발현되는 양상을 나타내었으며 암세포에서는 사이모신 베타 4나 HIF-$1{\alpha}$에 비해 강하게 발현되지 않았다. 위암, 간 혈관육종, 담낭 선암과 자궁 내막 선암에서 적당 수준의 VEGF 발현이 관찰되었으며 VEGF의 발현 양상 및 위치는 위암, 골육종, 지방종, 폐암, 간암, 담낭 선암, 식도 편평세포암, 대장 및 직장암, 신세포암을 포함하는 특정 암에서 사이모신 베타 4 및 HIF-$1{\alpha}$와 일치하는 것으로 관찰되었다.

Keywords

References

  1. Bock-Marquette, I., A. Saxena, M. D. White, J. M. Dimaio, and D. Srivastava. 2004. Thymosin beta4 activates integrin- linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432, 466-472. https://doi.org/10.1038/nature03000
  2. Cha, H. J., M. J. Jeong, and H. K. Kleinman. 2003. Role of thymosin beta4 in tumor metastasis and angiogenesis. J. Natl. Cancer Inst. 95, 1674-1680. https://doi.org/10.1093/jnci/djg100
  3. Grant, D. S., W. Rose, C. Yaen, A. Goldstein, J. Martinez, and H. Kleinman. 1999. Thymosin beta4 enhances endothelial cell differentiation and angiogenesis. Angiogenesis 3, 125-135. https://doi.org/10.1023/A:1009041911493
  4. Huang, H. C., C. H. Hu, M. C. Tang, W. S. Wang, P. M. Chen, and Y. Su. 2007. Thymosin beta4 triggers an epithelial- mesenchymal transition in colorectal carcinoma by upregulating integrin-linked kinase. Oncogene 26, 2781-2790. https://doi.org/10.1038/sj.onc.1210078
  5. Ji, P., S. Diederichs, W. Wang, S. Boing, R. Metzger, P. M. Schneider, N. Tidow, B. Brandt, H. Buerger, E. Bulk, M. Thomas, W. E. Berdel, H. Serve, and C. Muller-Tidow. 2003. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22, 8031-8041. https://doi.org/10.1038/sj.onc.1206928
  6. Jo, J. O., S. R. Kim, M. K. Bae, Y. J. Kang, M. S. Ock, H. K. Kleinman, and H. J. Cha. 2010. Thymosin beta4 induces the expression of vascular endothelial growth factor (VEGF) in a hypoxia-inducible factor (HIF)-1alpha-dependent manner. Biochim. Biophys. Acta 1803, 1244-1251. https://doi.org/10.1016/j.bbamcr.2010.07.005
  7. Kallio, P. J., I. Pongratz, K. Gradin, J. McGuire, and L. Poellinger. 1997. Activation of hypoxia-inducible factor 1alpha: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc. Natl. Acad. Sci. USA 94, 5667-5672. https://doi.org/10.1073/pnas.94.11.5667
  8. Kallio, P. J., W. J. Wilson, S. O'Brien, Y. Makino, and L. Poellinger. 1999. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J. Biol. Chem. 274, 6519-6525. https://doi.org/10.1074/jbc.274.10.6519
  9. Kobayashi, T., F. Okada, N. Fujii, N. Tomita, S. Ito, H. Tazawa, T. Aoyama, S. K. Choi, T. Shibata, H. Fujita, and M. Hosokawa. 2002. Thymosin-beta4 regulates motility and metastasis of malignant mouse fibrosarcoma cells. Am. J. Pathol. 160, 869-882. https://doi.org/10.1016/S0002-9440(10)64910-3
  10. Larsson, L. I. and S. Holck. 2007. Localization of thymosin beta-4 in tumors. Ann. N.Y. Acad. Sci. 1112, 317-325. https://doi.org/10.1196/annals.1415.005
  11. Larsson, L. I. and S. Holck. 2007. Occurrence of thymosin beta4 in human breast cancer cells and in other cell types of the tumor microenvironment. Hum. Pathol. 38, 114-119. https://doi.org/10.1016/j.humpath.2006.06.025
  12. Low, T. L., S. K. Hu, and A. L. Goldstein. 1981. Complete amino acid sequence of bovine thymosin beta 4: a thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations. Proc. Natl. Acad. Sci. USA 78, 1162-1166. https://doi.org/10.1073/pnas.78.2.1162
  13. Malinda, K. M., A. L. Goldstein, and H. K. Kleinman. 1997. Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells. FASEB J. 11, 474-481.
  14. Malinda, K. M., G. S. Sidhu, H. Mani, K. Banaudha, R. K. Maheshwari, A. L. Goldstein, and H. K. Kleinman. 1999. Thymosin beta4 accelerates wound healing. J. Invest. Dermatol. 113, 364-368. https://doi.org/10.1046/j.1523-1747.1999.00708.x
  15. Philp, D., A. L. Goldstein, and H. K. Kleinman. 2004. Thymosin beta 4 promotes angiogenesis, wound healing, and hair follicle development. Mech. Ageing Dev. 125, 113-115. https://doi.org/10.1016/j.mad.2003.11.005
  16. Philp, D., M. Nguyen, B. Scheremeta, S. St-Surin, A. M. Villa, A. Orgel, H. K. Kleinman, and M. Elkin. 2004. Thymosin beta4 increases hair growth by activation of hair follicle stem cells. FASEB J. 18, 385-387.
  17. Philp, D., S. St-Surin, H. J. Cha, H. S. Moon, H. K. Kleinman, and M. Elkin. 2007. Thymosin beta 4 induces hair growth via stem cell migration and differentiation. Ann. N.Y. Acad. Sci. 1112, 95-103. https://doi.org/10.1196/annals.1415.009
  18. Sanders, M. C., A. L. Goldstein, and Y. L. Wang. 1992. Thymosin beta 4 (Fx peptide) is a potent regulator of actin polymerization in living cells. Proc. Natl. Acad. Sci. USA 89, 4678-4682. https://doi.org/10.1073/pnas.89.10.4678
  19. Wang, W. S., P. M. Chen, H. L. Hsiao, H. S. Wang, W. Y. Liang, and Y. Su. 2004. Overexpression of the thymosin beta- 4 gene is associated with increased invasion of SW480 colon carcinoma cells and the distant metastasis of human colorectal carcinoma. Oncogene 23, 6666-6671. https://doi.org/10.1038/sj.onc.1207888